Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride versus dutasteride for benign prostatic hyperplasia
IRCT20260908070969N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in benign prostatic hyperplasia (BPH) comparing Finasteride arm with Dutasteride arm (2 arms). Primary endpoints: Serum PSA levels and Prostate volume. Started Sep 2025; status: completed.
02
Drugs
finasteridedutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20260908070969N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260908070969N1.